Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 4334
Journal of Alzheimers Disease & Parkinsonism received 4334 citations as per Google Scholar report
Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Lifestyle interventions for Dementia using the internet
3rd International Conference on Alzheimers Disease & Dementia
Veronika Vd Wardt
University of Nottingham, UK
Keynote: J Alzheimers Dis Parkinsonism
Abstract
Biography
Veronika completed her Masters in Developmental Psychology at Utrecht University/The Netherlands in 2006 and then started her PhD research at Loughborough University. She investigated the relationship between cognitive abilities and sports performance in people with intellectual disabilities, for which she developed and tested a computerized cognitive test battery. Her postdoctoral research included studies investigating the association between cognition, well-being and use of new technologies in older people and emotion recognition patterns in people with and without cognitive impairment. Her current projects examine antihypertensive treatment in people with dementia and the development of a falls intervention programme for people with mild cognitive impairment and early stage dementia.
